Open Access

Cardiac disease modelling

Event: ESC Congress 2018
Topic: Cardiac Biology and Physiology
Session type: Abstract Sessions
Date: 28 August 2018
Time: 11:00 - 12:30

Congress Session

6 presentations in this session

Can patient-derived iPSCs be applied to phenotypic cell-based high throughput screening assessment to distinguish between different types of long-QT syndrome?

Speaker: Mr D. Yoshinaga (Boston, US)
Thumbnail

Electrically silent and stimulable iPSC-derived cardiomyocytes using RNA-guided epigenome editing

Speaker: Professor J. Hulot (Paris, FR)
Thumbnail

Generation of disease specific iPSC-derived cardiomyocyte and investigation of their characteristics: study with clinically divergent female monozygotic twins with Danon disease.

Speaker: Doctor S. Yoshida (Kanazawa, JP)
Thumbnail

Exploring hypertrophic cardiomyopathy in iPSC-derived cardiomyocytes from patients with a novel autosomal recessive form of Noonan syndrome

Speaker: Doctor L. Cyganek (Gottingen, DE)
Thumbnail

A novel platform to maintain adult cardiac tissue in vitro: myocardial slices and electromechanical stimulation with physiological preload

Speaker: Mr S. Watson (London, GB)
Thumbnail

Functional analysis of induced pluripotent stem cell-derived cardiomyocytes from patients with hypoplastic left heart syndrome in engineered heart tissues

Speaker: Doctor Z. Zhang (Munich, DE)
Thumbnail

6 speakers from this session

Mr Daisuke Yoshinaga

Boston Children's Hospital, Boston (United States of America)
0 follower

Professor Jean-Sebastien Hulot

Paris Cardiovascular Research Center (PARCC), Paris (France)
11 presentations
0 follower

Doctor Shohei Yoshida

Kanazawa University Graduate School of Medicine, Kanazawa (Japan)
0 follower

Doctor Lukas Cyganek

University Medical Center of Gottingen (UMG), Gottingen (Germany)
0 follower

Mr Samuel Alexander Watson

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Zhong Zhang

German Heart Center of Munich, Munich (Germany)
0 follower

This platform is supported by

logo Novo Nordisk